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pro-inflammatory features
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Abstract
Background: Intestinal intraepithelial lymphocytes that reside within the epithelium of the intestine form one
of the main branches of the immune system. A majority of IELs express CD8α homodimer together with other
molecules associated with immune regulation. Growing evidence points to the WNT signaling pathway as a pivotal
piece in the immune balance and focuses on its direct regulation in intestinal epithelium. Therefore we decided to
investigate its role in IELs’ immune status determination.
Method: DSS colitis was induced in male C57BL mice. IELs were isolated from colon samples using mechanical
dissociation followed by percoll gradient purification and Magnetic-activated cell sorting. Phenotype and cytokine
production and condition with Wnts were analyzed by flow cytometry, real-time PCR or ELISA. Proliferation of
lymphocytes were evaluated using CFSE dilution. Cell responses after WNT pathway interference were also evaluated.
Results: Non-canonical WNT pathway elements represented by FZD5, WNT5A and NFATc1 were remarkably elevated
in colitis IELs. The non-canonical WNT5A skewed them into a pro-inflammatory category as measured by inhibitory cell
surface marker LAG3, LY49E, NKG2A and activated marker CD69 and FASL. Gaining of a pro-inflammatory marker was
correlated with increased IFN-γ production but not TNF whilst decreased TGF-β and IL-10. Both interrupting WNT5A/
PKC pathway and adding canonical WNT stimulants could curtail its immune-activating effect.
Conclusion: Canonical and non-canonical WNT signals act in opposing manners concerning determining CD8αα+ IELs
immune status. Targeting non-canonical WNT pathway may be promising in tackling inflammatory bowel disease.
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Background
Inflammatory bowel disease especially ulcerative colitis
(UC) is related to the overly activation of colonic epithe-
lial immunity [1, 2]. The intestinal epithelium is com-
posed of a monolayer of cells that, among other
functions, provides a physical barrier between the
antigen-laden lumen of the intestine and the sterile
environment beyond the basal layer. A large and diverse
community of immune cells populates the epithelium.
The most prevalent and most studied of these cells in-
clude the intraepithelial lymphocytes (IELs), which are
predominantly T cells and can be divided into two major
subsets of natural and induced IELs based on the
mechanisms by which they become activated and on the
cognate antigens that they recognize [3]. The primary
role of natural IELs seems to be ensuring the integrity of
the intestinal epithelium and maintaining local immune
quiescence. The majority of them express the CD8α
homodimers which instead of serving as a T cell co-
receptor similar to CD8αβ heterodimers on conventional
CD8+ T cells, have been postulated to be a repressor of
TCR signaling [4]. In addition, their ability to express
tolerogenic molecules such as LY49E and TGF-β further
accentuates features of immune regulation [5, 6].
The WNT family of proteins regulates cell prolifera-
tion and differentiation in normal tissues and in cancer
[7]. Growing evidence points out that the WNT signal-
ing pathway also acts as a pivotal piece in the immune
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balance thus increasing focuses have been set on its
direct regulation in intestinal epithelium [8–11]. Upon ac-
tivation by canonical WNTs, β-catenin translocates to the
nucleus, where it associates with TCF/LEF family tran-
scription factors to activate target gene expression. While
WNT/β-catenin has been ascribed a tumor stimulating
effect, it also seems to mediate anti-inflammatory effects
[12]. At the same time studies based on the modulation of
non-canonical WNT signaling downstream molecules
suggest a potential pro-inflammatory role. Its induced
transcription factor nuclear factor κB (NF-κB) is crucial
for inflammation, immunity and tissue homeostasis [13],
and appears to be a critical link between inflammation
and cancer [14]. Interestingly, mounting evidence has
shown that WNT/β-catenin can negatively regulate the
expression of a group of pro-inflammatory target genes of
NF-κB [15]. The high level of WNTs activity in colon and
the ability of WNTs to help determine the immune status
of effector cells prompt us to investigate the consequence
they endow with IELs.
In this study, we assessed the direct effects of WNTs
on the biology and functional responses of CD8αα+ IELs.
We reported that WNT3A directly induced immune-
regulatory cytokine production whereas WNT5A gave
rise to pro-inflammatory cytokines in these cells. The
canonical and non-canonical WNT ligands seemed to act
in opposing manners when ablate canonical WNT co-
receptor further enhanced WNT5A’s immune activating
outcomes. Inhibiting WNT5A downstream effector can
reverse pro-inflammatory phenotype of CD8αα+ IELs.
Moreover, WNT5A appeared to induce a Th1-like effect
in those IELs. The results suggest an important role for




4-week-old C57BL male mice were obtained from the
Shanghai SLAC Laboratory Animal CO. LTD (Shanghai
Laboratory Animal Center, Chinese Academy Sciences).
They were housed in environmentally-controlled condi-
tions (temperature 22 °C, with light cycle from 06:00 am
to 6:00 pm). DSS colitis model were established as
described elsewhere [16]. All animal experimentations
were approved by the Institutional Animal Use and Care
Committee of Shanghai University of Traditional Chinese
Medicine.
Cell purification
Intraepithelial lymphocytes were retained by mechanical
dissociation from 10 weeks old wild-type C57BL or DSS
induced colitis mice as described before [17]. In short,
mice intestine tissue was dissected and cut into 5 mm
pieces. Every gram of tissue was added into 5 ml of
5 mM EDTA/5 mM DTT solution to remove the
mucous and epithelium. Solution was gently shaken at
150 rpm under 37 °C for 15 min. A total of 3 times of re-
movals were carried out with dissociated cells collected
after each conduct. Density gradient step was done by re-
suspending cells in 40 % percoll and carefully laid on 80 %
percoll solution and centrifuged at 500 rcf under 4 °C for
20 min. The viability of yielding cells was around 90 %.
CD8αα+ lymphocytes were selected by magnetic activated
cell sorting using Miltenyi products (130-094-973 and
130-104-075) as the manufacturer instructed. The purity
of the CD8αα+ population was 85–95 %. Isolated cells
were maintained in RPMI-1640 (life Techenologies)
supplemented with fetal bovine serum (10 % v/v) (life
Techenologies), 100 U/mL penicillin-streptomycin (life
Techenologies), 2 mmol/L L-glutamine (life Techenologies),
anti-CD3 (10 ug/ml) (BD Pharmingen) and anti-CD28
(2 ug/ml) (BD Pharmingen). JURKAT and EL4 cells
were bought from ATCC and were cultured in RPMI 1640
supplement with the fetal bovine serum (10 % v/v).
Abs, chemicals and ELISA reagents
The following Abs were used to detect human(h) or
mouse(m) antigen for flowcytometry analysis: CD8α(m),
Clone 53–6.7, BD Pharmingen; LAG3(m), Clone C9B7W,
BD Pharmingen; LAG3(h), Clone 3DS223H, eBioscience;
LY49E(m), Clone CM4, eBioscience; NKG2A(m), Clone
20d5, BD Pharmingen; NKG2A(h), Clone 131411, R&D
Systems; FASL(m), Clone MFL3, eBioscience; FASL(h),
Clone NOK-1, eBioscience; CD69(m), Clone H1.2 F3, BD
Pharmingen; CD69(h), Clone L78, BD Pharmingen;
Granzyme B(m), Clone NGZB eBioscience; Granzyme
B(h), Clone GB11, BD Pharmingen; IL-4(m), Clone 11B11,
BD Pharmingen; NKG2D(m), Clone CX5, BD Pharmingen;
T-bet(m), Clone 04–46, BD Pharmingen; GATA3(m),
Clone L50-823, BD Pharmingen.
Primary Abs used for Western blot analysis were: Anti-
LRP6 antibody-N-terminal, Abcam; PKC-alpha [pT638]
Rabbit Polyclonal Antibody, Life Technologies; Phospho-
PKCα/β II (Thr638/641) Antibody, Cell Signaling; PKCdelta
Antibody, Thermo Scientific Pierce Antibodies; Phospho-
PKCdelta (Tyr311) Antibody, Cell Signaling; NFAT2
(D15F1) Rabbit mAb, Cell Signaling Technology; Anti-
Human/Mouse GAPDH Purified, eBioscience.
Chemicals used in function analysis: Wnt3a (315–20,
PeproTech); Wnt5a (645-WN-010, R&D Systems);
BisindolylmaleimideI (G2911, Sigma-Aldrich); Cyclo-
sporin A (30024, Sigma-Aldrich).
The following reagents were used for ELISA: Human
IL-10 Quantikine ELISA Kit, Mouse IL-10 Quantikine
ELISA Kit, Human TGF-beta 1 Quantikine ELISA Kit,
Mouse/Rat/Porcine/Canine TGF-beta 1 Quantikine ELISA
Kit, Human IFN-gamma Quantikine ELISA Kit, Mouse
IFN-gamma Quantikine ELISA Kit, Human TNF-alpha
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Quantikine ELISA Kit and Mouse TNF-alpha Quantikine
ELISA Kit. All were purchased from RnD systems.
CFSE labeling and flowcytometry detection
T cells were labeled with CFSE (21888, Sigma-Aldrich)
for 10 min at 37 °C, followed by 10 % FBS deactivation
and extensive washing, prior to culture. Proliferation
was assessed on D4 of culture. As for cytokine detection,
on the last day of culture, cells were stimulated for
4–6 h with PMA (10 ng/ml) and ionomycin (1 mg/ml;
both from peprotech) to enhance cytokine expression.
Intracellular stainings were performed as the manu-
facturer indicated (554714, BD Pharmingen). Flowcytome-
try analysis was performed on an LSR II flow cytometer
(BD Pharmingen).
RNAi
A siRNA sequence targeting the mouse (sc-37234, Santa
Cruz) or human (sc-37233, Santa Cruz) LRP6 were in-
troduced into EL4 or JURKAT cells using Lipofectamine®
RNAiMAX Reagent (Life Technologies) as indicated by
the manufacturer’s instruction. The efficacy of knock-
down was evaluated by rtPCR and western-blot.
Real-time PCR analysis
Total cellular RNA from cells of interest was extracted
using TRIzol (Life Technologies). We reverse transcribed
the total amount of RNA and quantify the cDNA con-
tent as the kit manufacturer instructed (RR037, RR820,
both from Takara). RNA samples were treated with
RNase-free DNase I (Invitrogen) before reverse tran-
scribed to eliminate contaminating genomic DNA. We
determined the expression of the mRNAs for human (h)
and/or mice (m) of interest using the primers listed in
supplement Table 1. Expression was normalized to the
level of β-actin in each sample.
Western blot
We lysed cells in RIPA buffer (Beyotime) supplemented
with protease and phosphatase inhibitors (Beyotime).
Equal amounts of protein was loaded on SDS PAGE and
blotted on nitrocellulose (Millipore). Membranes were
blocked and probed with Abs for LRP6 (1:1000), PKCα
(1:2000), Phospho-PKCα/β (1:1000), PKCδ (1:2000),
Phospho-PKCδ (1:1000), NFATc1 (1:2000) and GAPDH
(1:2000). Finally, proteins were visualized using ECL sys-
tem (Pierce).
Statistical analysis
Data is presented as mean values ± SEM, unless
otherwise indicated. Statistical significance between
sets of data was assessed with the two-tailed unpaired
Student t test.
Ethical approval and consent
All animal experimentations were approved by the
Institutional Animal Use and Care Committee of Shanghai
University of Traditional Chinese Medicine.
Results
Expression of WNT regulated genes were influenced by
colitis status in intraepithelial cells
To analyze the WNT signaling pathway elements’ ex-
pression levels in IELs during DSS colitis, we used rtPCR
to profile the expression of WNT related genes in both
distal colon tissue and isolated large intestine IELs. Al-
beit no statistically significant change was observed in
the en-bloc resection, expression of several WNT canon-
ical and non-canonical signaling elements were affected
in IELs from inflamed colon as compared to healthy
controls. Canonical WNT signaling pathway compo-
nents FZD1, FZD7 and WNT3A dropped in response to
the DSS treatment from day 4 to day 7, non-canonical
WNT ligand WNT5A, receptor FZD2 and FZD5 and
downstream NFATc1, quite on the contrary, were upreg-
ulated in IELs (Fig. 1). The transcription factor NFATc1
was reported to play an essential role in the pathogenesis
of inflammatory bowel disease and augment a number
of inflammation-associated genes. All those mRNA ex-
pression modulations suggest an involvement of WNT
signaling pathway in IELs’ immuno-activation.
The Canonical and non-canonical WNT ligands act in
divergent ways in regulating CD8αα+ IELs immune
response
We next performed a phenotypic analysis of CD8αα+ cells
within the IELs gate after canonical or non-canonical
WNT stimulants. CD8αα+ cells were found in the epithe-
lium of the colon and constituted nearly 50 % of all CD45
+CD3ε+ cells present within the epithelium. Isolated
CD8αα+ IELs were cultured in medium alone or in the
presence of WNT3A or WNT5A. Culturing with canon-
ical WNT stimulants rapidly upregulated immune-
regulating surface marker LAG3, LY49E and NKG2A
while decreased activating marker FASL and CD69. At the
same time, non-canonical ligand had noticeably aug-
mented FASL and CD69, while had no effect on LAG3
and LY49E and only moderately upregulated NKG2A.
Thus, the WNT signals acted on the CD8αα+ IELs on a
dichotomous way when canonical signals seemed to allow
those cells retain a tolerogenic phenotype (Fig. 2a and b).
Further analysis was performed on the ability of
WNT3A and WNT5A to induce cytokine production in
freshly isolated CD8αα+ IELs from mouse colon. Over-
night stimulation of IELs with recombinant WNT3A
stimulated secretion of the immune regulatory cytokine
IL-10 and TGF-β. WNT5A also induced TGF-β yet to a
lesser degree. The inflammatory mediator IFN can only
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Fig. 1 RT-PCR analysis of WNT pathway genes of colon tissues (up) and isolated IELs (down). Cells were isolated from DSS mice models and
MACS-enriched. IELs represent total CD3ε + cells. mRNA expression was compared to the expression observed in healthy counterparts. Real-time
PCR was performed in duplicate and samples were normalized to β-actin expression, with standard deviations indicated. D4: the fourth day of
initiating DSS treatment, D7: the seventh day of initiating DSS treatment
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Fig. 2 (See legend on next page.)
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be induced by WNT5A. Interestingly, though increased
on mRNA level by WNT5A, tumor necrosis factor (TNF)
protein expression was not modulated by either WNT5A
or WNT3A. Thus, WNTs can promote CD8αα+ IELs pro-
duction of immune regulatory cytokines (Fig. 2c).
Because WNT signals regulate the survival of lymph-
oid cells, we next examined whether WNTs were in-
volved in CD8αα+ IELs survival. The viability of
mechanically dissociated IELs dropped quickly during ex
vivo culture, on the fourth day, the overall survival
dropped to around 50 %. As shown in Fig. 2d and e,
WNT5A conditioned cells were remarkably rigorous as
determined by annexin V/PI staining. On the fourth day,
around 70 % of IELs were still viable. WNT3A can also
moderately enhance ex vivo cell viability. Both WNT3A
and WNT5A could augment IELs proliferation as
assessed by CFSE dilution assay (Fig. 2f ).
To serve as additional controls we also investigated the
response of CD8αβ + IELs after conditioned with WNTs.
The antigen-experienced cytotoxic T cells protect the hosts
against various infectious agents. WNT5A can significantly
enhance the activation marker FASL and CD69. Canonical
WNT signal modestly activated these cells to a lesser de-
gree than the WNT5A, suggesting WNT pathways acting
in a cell-type specific manner even within the IELs popula-
tion (Fig. 3).
Canonical and non-canonical WNT stimulants act in
opposing manners
We then examined the WNT signals’ effects on two T
lymphocyte cell lines: the human originated JURKAT
and C57BL originated EL4. WNT5A can significantly
enhance the activation marker FASL and CD69 in both
cell lines while only modestly affect the regulating
markers. That is probably due to the devoid of tolero-
genic ability in these two cell lines. On the contrary,
canonical WNT signals continually exert an immune-
modulating role when it dampens CD69 and promote
LY49E expression in JURKAT cells. WNT3A can also
decrease FASL and CD69 expression while increasing
LAG3 expression in EL4 cells thus model them into an
less immune-active status (Fig. 4a and b).
LRP-6 is a transmembrane co-receptor for Wnts that
binds to Frizzled (FZD) receptors and thereby to the
WNT/β-catenin signaling cascade whose normal activity
have recently been shown to be critical for inhibition of
non-canonical WNT pathway, including Rac1, PKC,
RhoA and ROCK [18]. To establish the link between
(See figure on previous page.)
Fig. 2 Markers and cytokines expression by CD8αα+. Sorted intestinal CD8αα+ IELs from DSS colitis mice were treated with 0.4 ng/ml WNT3A or
0.4 μg/ml WNT5A for 24 h as indicated. a Expression of surface markers in CD8αα+ cells. b Mean fluorescence intensity (MFI) was expressed as
means ± SEM. Data represents three mice from two individual experiments. c Expression of cytokines in terms of mRNA (up) and protein quantity in
supernatants (down). Conditioned with WNTs reduces apoptosis and enhances proliferation of CD8αα+ IELs. d Survival assessed by annexin V/PI
staining for CD8αα+ IELs. e Statistical analysis for annexin V/PI-negative cells following treatment with results of three repeat experiments. f CFSE-labeled
CD8αα+ IELs cultured for 4 days conditioned with WNTs. Data presented with means ± SEM from three independent experiments are shown. *p < 0.05,
**p < 0.01, ***p < 0.005,ns: None-significant
Fig. 3 Immuno-phenotype of CD8αβ+ cells conditioned with WNTs. Sorted intestinal CD8αβ+ IELs from DSS colitis mice were treated with
0.4 ng/ml WNT3A or 0.4 μg/ml WNT5A for 24 h as indicated. Mean fluorescence intensity (MFI) was expressed as means ± SEM. Data represents
three mice from two individual experiments. *p < 0.05, **p < 0.01, ***p < 0.005
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canonical WNT and non-canonical WNT pathway,
LRP6 expression was knocked down in both JURKAT
and EL4 cells using siRNA technique. Cells were then
treated with WNT5A and WNT3A. As expected, LRP6
knockdown led to increased expression of non-canonical
WNT proteins phospho-protein kinase C (PKC) α,
PKCδ and their phosphorylated forms. These findings
also associated loss of function of LRP6 with increased
activation of nuclear factor of activated T cells (NFATc1),
the non-canonical WNT effector which had been impli-
cated in both Crohn’s Disease and Ulcerative Colitis [19]
(Fig. 4c). WNT5A can trigger intracellular calcium flux,
which can lead to the activation of PKC, calcium-
dependent molecules such as calmodulin-dependent
protein kinase II or calcineurin, and then NFATc1.
Nucleo-translocation/activation of NFATc1 in lamina
propria mononuclear cells was found in ulcerative col-
itis. As expected, with deactivated LRP6 and muffled
WNT canonical pathway, both NFAT and its dephos-
phorylated form were boosted, implicating a greater
ability to activate its downstream genes including IFN.
We next examined whether WNT3A can act against
WNT5A in IFN production. Stimulation of both
JURKAT and EL4 cells with recombinant WNT3A
(0.1, 0.5, 2.5 ng/ml) showed a clear dose dependent in-
hibition of IFN production comparing to WNT5A alone
(Fig. 4d),which was in compliance with NFATc1 and its
dephosphorylation form protein level. These results im-
plicate WNT3A acts in antagonist with WNT5A in acti-
vating PKCα-Cn-NFAT-IFN axis. WNT5A may skew T
cells into a pro-inflammation characteristic while WNT3A
can help maintain an immune-modulation phenotype.
Interrupt WNT5A-PKC-NFATc1 pathway could curtail its
immune-activating effect
Selective inhibitors were applied to further validate the
role of PKCα-Cn-NFAT-IFN axis in DSS induced acti-
vated CD8αα+ IELs. 24 h of incubation with the potent
and selective PKC inhibitor Bisindolylmaleimide (BIS)
abated proinflammatory markers FASL, granzyme and
NKG2D but not CD69 and IL-4. At the same time, using
NFATc1 inhibitor CsA can significantly deactivate IELs
as assessed by suppressed CD69, FASL, granzyme and
NKG2D expression. However, comparing to WNT3A,
both of the two inhibitors could only moderately endow
an immune-regulatory trait as judged from LY49E,
NKG2A and LAG3 expression. Since both granzyme
and NKG2D are Th1 related immune molecules, we
then looked in to the Th1 transcription factor T-bet ex-
pression after PKC and NFATc1 inhibition. In compli-
ance with cell surface markers panel alterations above, it
decreased after both PKC and NFATc1 inhibition. The
Th2 cytokine IL-4 and transcription factor GATA-2 ex-
pression level were unaffected by the treatment (Fig. 5a).
A series of cytokines’ expression levels were also exam-
ined using rtPCR after PKC or NFATc1 inhibition. The
downstream effectors C-MYC and PKCA were noticeably
decreased after BIS employment together with inflamma-
tory IL-2 and IFN as well as IL-2 receptor. TNF level were
also slightly confined. CsA demonstrated an even greater
ability to suppress immune response as measured from
IL-2, IL-15, IL-12, IFN and TNF mRNA transcription
level. Interestingly, inhibition of PKCα-Cn-NFAT axis
alone could not boost IL-10 or TGFβ production. The
above findings implicate activation of non-canonical Wnt
signal in colon epithelial inflammation and identify the
PKCα-Cn-NFAT-IFN axis as a potential target for drug
development against inflammation (Fig. 5b).
Discussion
Previous studies of β-catenin–dependent mechanisms in
immune tolerance provided the rationale for assessing
the role of WNTs in IELs function. In this study, we
chose to examine WNT3A as a representative ligand
that characteristically activated the canonical β-catenin
pathway and WNT5A, which, in most cellular system,
mediates non-canonical PKC signaling. In a lot of pre-
vious work, those two systems have been found to act
opposing roles in stimulating immune responses. In this
study, we were able to show that the canonical WNT
signal and non-canonical WNT signal differentially in-
duced anti- or pro-inflammatory immune responses in
IELs. Selectively inhibiting the WNT5A-PKCα-NFAT
axis could ameliorate the inflammation related processes
within IELs. At the same time, siRNA knockdown of ca-
nonical WNT signaling co-receptor removed the brake
and resulted in further activation of non-canonical
WNT pathway. We used several most commonly as-
sessed markers to conduct immune phenotyping in
CD8αα+ IELs. LAG3 negatively regulates T-cell function
and homeostasis [20, 21], and it is an essential compo-
nent for the suppressive function of CD4+CD25+ regula-
tory T cells [22]. The LY49E NK receptor is a unique
inhibitory receptor, presenting with a high degree of
(See figure on previous page.)
Fig. 4 Immuno-phenotype of JURKAT and EL4 cells conditioned with WNTs. a Expression of surface markers in JURKAT (up) and EL4 (down) cells.
Data represent three mice from two individual experiments. b Mean fluorescence intensity (MFI) was expressed as means ± SEM. Data represent
from two individual experiments. c Western blot analysis demonstrates the greater activities of the WNT5A-PKC pathway in JURKAT and EL4 cells
compared to wild type. d RT-PCR analysis of IFN of JURKAT (up) and EL4 (down). Cells were treated with different WNTs combination as indicated.
mRNA expression was normalized to GAPDH expression. *p < 0.05, **P < 0.01, ***p < 0.005
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conservation among mouse strains and expression on
both NK cells and colonic intraepithelial-localized T cells
including CD8αα+ IELs. LY49E does not or only weakly
recognize MHC-I, Sequestration of LY49E resulted in a
2-fold increase of the response of IELs to TCR stimula-
tion [23, 24]. NKG2A is an inhibitory C-type lectin most
commonly found on NK cells and some cytotoxic CD8+
T cells. The receptor–ligand binding of NKG2A to the
MHC class Ib antigen HLA-E (human leukocyte antigen
E; Qa-1b in mice) suppresses effector cell cytotoxic ac-
tivity. NKG2A may also serve to prevent or reduce an
inflammatory neutrophil-driven positive-feedback loop,
via inhibition of cytokines (such as IL-6 and IL-17), thus
subsequently impacting on overall neutrophil recruit-
ment. In addition, NKG2A expression on NK cells pro-
tected mice from DSS-induced colitis development.
Additional data from human studies supported a pos-
sible role of NK receptor expression in ulcerative colitis
development and progression [25]. Although self-
reactive CD8αα+TCRαβ+ natural IELs are normally im-
munologically quiescent, they have a potent antigen-
experienced cytotoxic effector phenotype, which is charac-
terized by high levels of granzymes, CD95 ligand (CD95L;
also known as FASL) and CD69. Like activated splenic
CD8+ cells, granzymes are secreted by IELs and induce
apoptosis in target cells while FASL induces apoptosis fol-
lowing engagement of Fas on target cells [26].
Under normal conditions, CD8αα+ IELs are not self
destructive, and evidence indicates that self-tolerance
and regulatory features are associated with the molecules
they secrete. TGF-β and IL-10 are critical participants in
the maintenance of tolerance and immune homeostasis,
acting on innate immune and stromal cells to suppress
production of pro-inflammatory cytokines or chemo-
kines and modulate immune responses of epithelial cell
components nearby [27]. They also have important func-
tions in protection at mucosal surfaces: IL-10 acts on
epithelial cells to promote epithelial barrier integrity
[28], and TGF-β stimulates IgA production [29] and acts
on T cells to support the generation and survival of per-
ipheral Foxp3+ Tregs [30]. Whether the TGF-β is se-
creted in biologically active form in this setting remains
to be determined.
Newly found results show that the signature Th1 tran-
scription factor T-bet can direct both the development
of CD8αα+ IELs and its further differentiation and ex-
pansion in response to IL-15 [31]. In our study, the
WNT5A signal seems to induce a Th1 immune response
in IELs as characterized by a remarkable IFN produc-
tion, up-regulation of granzymes and FASL [32]. We
Fig. 5 Markers and cytokines expression by CD8αα+ treated by WNT5A-PKC pathway inhibition. a Expression of surface or intracellular markers
in CD8αα+ cells. b RT-PCR analysis of cytokines. Samples were normalized to β-actin expression. Data presented with means ± SEM from three
independent experiments
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managed to find that the intracellular T-bet level also
increased after non-canonical WNT activation while the
Th2 master transcription factor GATA-3 was un-
changed, indicating the significance of Th1-like pathway
in their mature state functioning. However, we also ob-
served an enhanced expression of intracellular NFATc1
and its dephosphorylated form, which was the hint of
Th2 type of response. Yet we did not find the IL-4 pro-
duction augmentation, which shall be result of NFATc1
transcriptional activation [33]. Still some other study
showed that activation of the canonical WNT–Frizzle
signal would induce the accumulation of β-catenin in
Th2 cells and promoted GATA3 transcription [34],
which was in contrast with our findings. Those diverse
modifications suggest there may be a cell specific reac-
tion to the WNT cascading thus further investigations
are needed to address the exact intracellular signaling
network reprogrammed by WNT ligands.
Recent studies indicate that besides basic duty of cell-
fate specification, progenitor-cell proliferation and the
control of asymmetric cell division, WNT proteins also
regulate effector T-cell development, regulatory T-cell
activation and dendritic-cell maturation. Growing evi-
dence points to the WNT signaling pathway as a pivotal
piece in the immune balance ranging from anti-tumor
immunity to auto-immunity related disease [8, 15, 35].
WNT/β-catenin pathways in human melanoma may be
involved in immune-suppression and immune-resistance
in both induction and effector phases of antitumor im-
mune responses. β-catenin-accumulated melanoma have
activities to impair DC maturation and to induce pos-
sible regulatory DCs both in culture and in implanted
mice model. Those β-catenin-overexpressed melanoma
cells can also inhibit IFN-γ production by melanoma-
specific CTLs in an IL-10-independent manner and is
more resistant to CTL lysis in vitro and in vivo [36].
Other evidences showed that WNT ligand-mediated ac-
tivation of β-catenin signaling in DCs was critical for
promoting tolerance and limiting neuro-inflammation.
Loss of LRP5/6-β-catenin-mediated signaling in DCs led
to increased production of pro-inflammatory cytokines
and decreased production of anti-inflammatory cyto-
kines such as IL-10 and IL-27 [37]. Co-stimulation with
LPS and WNT3A can lead to a significant increased
IL-10 expression and a down-regulation of pro-
inflammatory cytokines TNFα, IL-1B, and IL-6 in glial
cells [38]. WNT/β-catenin signaling can also trigger
anti-inflammatory effect in fibroblasts by selectively
inhibiting the expression of a pro-inflammatory subset
of IL-1β-induced NF-κB target genes [15].
However, the effects brought about by WNT3A has
highly cellular specificity. The activation of WNT signaling
reduced Treg-mediated suppression has been reported
both in vitro and in vivo [39], possibly through inducing
of expression of RORγt, the signature transcription factor
of Th17 cells [40]. Those variances further emphasize the
complex of immune cell fate determination.
On the other hand, several changes observed in
WNT5A-treated cells have been associated with pro-
inflammatory responses whereas WNT5A activates non-
canonical signaling and can even antagonize the canonical
pathway. For example, non-canonical WNT expression is
increased during infection and inflammation: WNT5A is
upregulated in arthritis synovial tissue, atherosclerotic pla-
ques, psoriatic or wounded skin, and in inflammatory
bowel disease [41]. In fact, the established role of non-
canonical WNT-PKCα axis has prompt development of
PKC inhibition in clinical setting. A well designed study
proved that inhibition of PKCα pathway using Sorastaurin
can stabilize Treg phenotype as evidenced by maintenance
of high Foxp3 and CD25 expression, and lack of IL-17A
and IFNγ production and has shown efficacy in clinical
trials of psoriasis [42]. At the same time, restraining PKC
pathway also demonstrated protection against ischemia-
reperfusion injury and confer renal graft protection in
rat models [43]. The general potent competence of
Sotraustaurin to deactivate T cells has made it into Phase
II renal and liver transplantation clinical trials.
Finally, although tolerance toward innocuous antigens
from the diet or from resident non-invasive commensals
is crucial for IELs to maintain the homeostasis of intes-
tine, suppression of the immune response is undesirable
in the context of tumor immunity. WNTs are frequently
overexpressed in cancers [7], and their immune suppres-
sive and tolerogenic effects on IELs could contribute to
tumor genesis especially in the case of ulcerative colitis
which has an estimated higher risk of developing inflam-
mation related colorectal cancer [44].
Conclusion
In this work we managed to demonstrate that canonical
and non-canonical WNT signals act in opposing manners
when determine CD8αα+ IELs immune status, as WNT5A
can program those cells with a pro-inflammatory feature.
Targeting non-canonical WNT pathway may be promising
in tackling inflammatory bowel disease.
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